CELG..(triple average daily volume) perhaps my favorite biotech (with ABSC, MOGN, IMMU, CEGE and GLGC) is looking quite excellent. CELG has a future and its been a longer term play than some of the others. Its losing less and less money every year as you can see on the results of this quarters loss of -($0.05) versus -(0.13).. If you have a little patience CELG should be earning about $0.38, an increase of 750% by December 2001, not a long way off at all considering it will probably move up until that 'golden' time.
Celgene Corporation Announces First Quarter Results
WARREN, N.J., April 27 /PRNewswire/ -- Celgene Corporation (Nasdaq: CELG - news) announced today results for the first quarter ended March 31, 2000. Net revenues were $11.9 million compared with $4.3 million for the comparable quarter in 1999, an increase of 176%. Net revenues consisted of $11.7 million from sales of Thalomid©(thalidomide) and $200,000 of revenue from research contracts. The $11.7 million in Thalomid sales represents a 30% increase over the previous quarter. On April 17, 2000, Nasdaq commenced reporting the Company's common share price on a split adjusted basis, reflecting the three- for-one stock split. All share and per share amounts reported have been restated in the consolidated statements of operations to reflect the stock split. The net loss for the first quarter 2000 was $3.1 million, or $0.05 per share, compared to a net loss of $6.6 million or $0.13 per share for the comparable 1999 period. |
